Plaxgen Inc
895, Mowry Avenue
Suite 101D
Fremont
California
94538
Tel: 510-894-0304
Fax: 510-894-3398
Website: http://www.plaxgen.com/
Email: info@plaxgen.com
About Plaxgen Inc
Founded in 2007, Plaxgen is a biodiagnostics company with a unique diagnostic platform to personalized medicine. We are focused on developing innovative technology for clinical diagnostics and the discovery of effective therapeutics to treat a broad spectrum of plaque-related diseases, including Alzheimer’s disease (AD) and atherosclerosis. Plaxgen’s proprietary Plaque Array platform was developed to detect and characterize serum-derived particles containing cholesterol or amyloid beta protein (abeta), tau and a-synuclein.YEAR FOUNDED:
2007
LEADERSHIP:
Founder and CEO: Shanmugavel Madasamy
FOLLOW PLAXGEN:
Tweets by Plaxgen
2 articles about Plaxgen Inc
-
Plaxgen Plaque Array Lipid-Modifying Drugs Study Published in Journal of Visualized Experiments
11/13/2017
Plaxgen announced that new research exploring the effect of lipid-lowering drugs, including statins, on the morphology of cholesterol particles in human serum samples was published in the peer-reviewed journal, "JOVE".
-
Plaxgen Statin Study Published In Cardiology Journal
10/3/2016